1 / 3

Vaccine Contract Manufacturing Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026

Pharmaceutical and biopharmaceutical companies are focusing more on their respective core strengths to manage the rising price pressure. <br>

rajbisen
Download Presentation

Vaccine Contract Manufacturing Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Vaccine Contract Manufacturing Market - Global Vaccine Contract Manufacturing Market - Global Industry Insights, Trends, Outlook, and Opportunity Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026 Analysis, 2018–2026 Pharmaceutical and biopharmaceutical companies are focusing more on their respective core strengths to manage the rising price pressure. Thus, the demand for contract manufacturing is increasing. However, vaccine manufacturing is a complex venture, in which safety, effectivity, and consistency are the most challenging part for the manufacturers. It offer many services that include production process, construction and operation of manufacturing product, cell line development, fermentation, process optimization, and analytical characterization, which fuels growth of the global vaccine contract manufacturing market. Request Sample Copy of Research Report @ Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1083 https://www.coherentmarketinsights.com/insight/request-sample/1083 Increase in research activities for new vaccines and availability of funds for the same could be Increase in research activities for new vaccines and availability of funds for the same could be the key growth factor of vaccine contract manufacturing market the key growth factor of vaccine contract manufacturing market Soligenix Inc. received a fund of around US$ 2.5 million for the contract of bioterror vaccine from National Institute of Allergy and Infectious Diseases (NIAID) in August 2017. The fund is granted for good manufacturing practices (GMP) of RiVax bulk drug substances and finished drug manufacturing to conduct future preclinical, clinical, and efficacy studies. Soligenix is aiming to develop advanced Soligenix's thermostabilization technology (ThermoVax) in combination with ricin toxin vaccine candidate – RiVax. The studies are conducting to prevent the effects of ricin exposure. Colorado State University’s (CSU) vaccine manufacturing facility, BioMARK, is developing a vaccine against a mosquito borne viral pathogen, which causes Venezuelan equine encephalitis (VEE). The U.S. Department of Defense (DoD) has funded around US$ 3 million to BioMARK for the development of this vaccine The purpose of this vaccine is to protect U.S. soldiers from fatal mosquito-borne pathogen. However, CSU is a subcontractor in vaccine project of Battelle

  2. and DoD’s Medical Countermeasure Systems Joint Vaccine Acquisition Program. CSU is determined to develop vaccine against aerosolized viruses to protect U.S. soldiers. Emergent BioSolutions agreed to sign a contract with the Centers for Disease Control and Prevention (CDC) for the manufacturing of BioThrax anthrax vaccine in 2016. According to the contract, Emergent will supply over 29 million doses of BioThrax anthrax vaccine in five years period of worth around US$ 911 million. Moreover, Biomedical Advanced Research and Development Authority planned to order more Bio Thrax worth US$ 100 million. This would further augment growth of the global vaccine contract manufacturing market in the near future. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Vaccine Contract Manufacturing Market Research Objective and Assumption • Vaccine Contract Manufacturing Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Vaccine Contract Manufacturing Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Vaccine Contract Manufacturing Market, By Regions • Vaccine Contract Manufacturing Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Vaccine Contract Manufacturing Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Vaccine Contract Manufacturing Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Vaccine Contract Manufacturing Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion

  3. Increasing prevalence of various viral and bacterial infections is expected to fuel growth of the Increasing prevalence of various viral and bacterial infections is expected to fuel growth of the market market According to World Health Organization (WHO), in 2016, around three to five million cases were recorded with severe illness and around 250,000 to 500,000 deaths were estimated due to influenza worldwide. In 1952, Centers for Disease Control and Prevention (CDC) collaborated with the World Health Organization’s (WHO), under the program - Global Influenza Surveillance and Response System (GISRS). The GISRS network consist of around 142 National Influenza Centers (NICS) worldwide, which are conducting influenza surveillance and viral trends in 112 countries. The study helps in research and analysis of influenza pattern and may contribute to develop candidate vaccines. This in turn, fuels growth of the vaccine contract manufacturing market. Request For Customization of Research Report @ Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1083 https://www.coherentmarketinsights.com/insight/request-customization/1083 About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related